PS79. Gender differences in sunshine increased antidepressant placebo effect
نویسندگان
چکیده
s | 27 was taking 1.26 ± 0.51 types of ADs and the AAP augmentation group 1.31 ± 0.54, plus 1.06 ± 0.19 AAPs. At 2 weeks, response was observed in 11 patients (35.48%) in the AD group and 18 patients (35.29%) in the AAP augmentation group (χ2 = 0, p = 1). At week 8, 16 (52.44%) and 27 patients (52.94%) achieved remission (χ2 = 0, p = 1), respectively. However, baseline HDRS-17 total scores were 18.55 ± 5.73 and 22.39 ± 6.14 (t = 2.819, p < 0.01) for the AD and AAP groups, respectively. Conclusion: Compared with AD treatment, AAP augmentation did not show a more rapid response nor greater remission rates. Considering that the AAP augmentation group had more severe depressive symptoms at baseline, AAP augmentation may be effective in severe MDD. PS79 Gender differences in sunshine increased antidepressant placebo effect Joël Gailledreau, Béatrice Gailledreau,Nathalie Desbonnet, Philippe
منابع مشابه
PS81. A MEGA-ANALYSIS OF FIXED-DOSE TRIALS REVEALS DOSE-DEPENDENCY, A RAPID ONSET OF ACTION AND A RESPECTABLE EFFECT SIZE FOR THE SYMPTOM-REDUCING EFFECTS OF SSRIs IN ADULT MAJOR DEPRESSION
s | 27 was taking 1.26 ± 0.51 types of ADs and the AAP augmentation group 1.31 ± 0.54, plus 1.06 ± 0.19 AAPs. At 2 weeks, response was observed in 11 patients (35.48%) in the AD group and 18 patients (35.29%) in the AAP augmentation group (χ2 = 0, p = 1). At week 8, 16 (52.44%) and 27 patients (52.94%) achieved remission (χ2 = 0, p = 1), respectively. However, baseline HDRS-17 total scores were...
متن کاملLessons learned from placebo groups in antidepressant trials.
This comprehensive review provides an overview about placebo and nocebo phenomena in antidepressant trials. Improvements in the placebo groups may partly be explained through methodological issues such as natural course of depression and regression to the mean, but also fundamentally reflect investigators' and participants' expectations. A meta-analysis by our group of 96 randomized placebo-con...
متن کاملRelative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
Although early antidepressant clinical trials simply relied on a clinician's judgment as to whether a depressed patient clinically improved or not, the Hamilton Depression (HAM-D) rating scale has become the 'gold standard' to assess the efficacy of new antidepressants. The alternative Montgomery-Asberg Depression Rating Scale (MADRS) has not achieved general acceptance. However, its ease of us...
متن کاملThe antidepressant debate continues
In her March 2002 editorial, Dr Moncrieff raises doubts about the efficacy of antidepressant drugs, and argues that side-effects of the active drug may explain some of the differences owing to the associated increased expectancy of a positive effect. Our 24-week study (Malt et al, 1999) comparing the efficacy of empathic primarycare counselling and support combined with placebo, a selective ser...
متن کاملThe antidepressant debate continues
In her March 2002 editorial, Dr Moncrieff raises doubts about the efficacy of antidepressant drugs, and argues that side-effects of the active drug may explain some of the differences owing to the associated increased expectancy of a positive effect. Our 24-week study (Malt et al, 1999) comparing the efficacy of empathic primarycare counselling and support combined with placebo, a selective ser...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 19 شماره
صفحات -
تاریخ انتشار 2016